Effects of estrogen therapy on well-being in postmenopausal women without vasomotor complaints

Maturitas

Volumn 36, Issue 2, 2000, Pages 123-130

  Skarsgård, Constance ^a   Göran, E Berg ^a   Ekblad, Sara ^a   Wiklund, Ingela ^b,c   Hammar, Mats L ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Double blind study; Estrogen therapy; Menopause; Well being

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESTROGEN THERAPY; FEMALE; HUMAN; MENTAL HEALTH; POSTMENOPAUSE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; WELLBEING;

ADMINISTRATION, CUTANEOUS; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0342409424     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(00)00141-9     Document Type: Article

References (50)

1. Hunter M.S. Predictors of menopausal symptoms: psychosocial aspects. Bailliere's Clin. Endocrinol. Metab. 7:1993;33-45.
2. Dennerstein L. Well-being, symptoms and the menopausal transition. Maturitas. 23:1996;147-157.
3. O'Connor V.M., Del Mar C.B., Sheehan M., et al. Do psycho-social factors contribute more to symptom reporting by middle-aged women than hormonal status? Maturitas. 20:1995;63-69.
4. Bungay G.T., Vessey M.P., McPherson C.K. Study of symptoms in middle life with special reference to the menopause. Br. Med. J. ii:1980;181-183.
5. Hunter M., Battersby R., Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas. 8:1986;217-228.
6. Hunter M. The South-East England longitudinal study of the menopause. Maturitas. 14:1992;117-126.
7. Jaszmann L. Epidemiology of climacteric and post-climacteric complaints. Front. Horm. Res. 2:1973;22-34.
8. Ballinger C.B. Psychiatric morbidity and the menopause; screening of general population sample. Br. Med. J. 3:1975;344-346.
9. Holte A., Mikkelsen A. The menopausal syndrome: a factor analytic replication. Maturitas. 13:1991;193-203.
10. Kaufert P.A., Gilbert P., Tate R. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas. 14:1992;143-155.
11. Collins A., Landgren B.-M. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study. Maturitas. 20:1995;101-111.
12. Holte A. Influences of natural menopause on health complaints: A prospective study of healthy Norwegian women. Maturitas. 14:1992;127-141.
13. Dennerstein L., Smith A.M.A., Morse C., et al. Menopausal symptoms in Australian women. Med. J. Aust. 159:1993;232-236.
14. McKinlay J.B., McKinlay S.M., Brambilla D. The relative contributions of endocrine changes and social circumstances to depression in mid-aged women. J. Health Soc. Behav. 28:1987;345-363.
15. Gath D., Osborn M., Bungay G., et al. Psychiatric disorder and gynaecological symptoms in middle aged women: a community survey. Br. Med. J. 294:1987;213-218.
16. Dennerstein L., Smith A.M.A., Morse C. Psychological well-being, mid-life and the menopause. Maturitas. 20:1994;1-11.
17. McKinlay S.M., Brambilla D.J., Posner J.G. The normal menopause transition. Maturitas. 14:1992;103-115.
18. Wiklund I., Karlberg J., Mattson L.-Å. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study. Am. J. Obstet. Gynecol. 168:1993;824-830.
19. Channon L.D., Ballinger S.E. Some aspects of sexuality and vaginal symptoms during menopause and their relation to anxiety and depression. Br. J. Med. Psychol. 59:1986;173-180.
20. Hammar M., Berg G., Fahraeus L., Larsson-Cohn U. Climacteric symptoms in an unselected sample of Swedish women. Maturitas. 6:1984;345-350.
21. Wiklund I., Holst J., Karlberg J., et al. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas. 14:1992;211-224.
22. Wiklund I., Berg G., Hammar M., et al. Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas. 14:1992;225-236.
23. Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin. Obstet. Gynecol. 4:1977;31-47.
24. Dennerstein L., Burrows G.D., Hyman G.J., Sharpe K. Hormone therapy and affect. Maturitas. 1:1979;247-259.
25. Padwick M.L., Siddle N.C., Lane G., et al. Oestriol with oestradiol verses oestradiol alone: a comparison of endometrial, symptomatic and psychological effects. Br. J. Obstet. Gynecol. 93:1986;606-612.
26. Thomson J., Oswald I. Effects of oestrogen on the sleep, mood, and anxiety of menopausal women. Br. Med. J. ii:1977;1317-1319.
27. Erlik Y., Tataryn I.V., Meldrum D.R., et al. Association of waking episodes with menopausal hot flushes. J. Am. Med. Assoc. 245:1981;1741-1744.
28. Wiklund I. Methods of assessing the impact of climacteric complaints on quality of life. Maturitas. 29:1998;41-50.
29. Durst N., Maoz B. Changes in psychological well-being during postmenopause as a result of estrogen therapy. Maturitas. 1:1979;301-315.
30. Limouzin-Lamothe M.A., Mairon N., Joyce C.R.B., Le Gal M. Quality of life after the menopause: Influence of hormonal replacement therapy. Am. J. Obstet. Gynecol. 170:1994;618-624.
31. Ditkoff E.C., Crary W.G., Cristo M., Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet. Gynecol. 78:1991;991-995.
32. Skarsgård C., Björs E., Nedstrand E., Wyon Y., Hammar M. Do women's premenstrual symptoms and their mother's climacteric history predispose to their own vasomotor symptoms? Menopause. 3:1996;133-139.
33. Dupuy H.J. The Psychological General Well-Being (PGWB) Index. Wenger N.K., Mattson M.E., Furberg C.F., Elinson J. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. 1984;170-183 Le Jacq, USA.
34. Kupperman H.S., Blatt M.H.G., Wiesbader H., Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J. Clin. Endocrinol. Metab. 13:1953;688-703.
35. Naughton M.J., Wiklund I. Dimension-specific HRQL measures. Qual. Life Res. 2:1993;397-432.
36. Wiklund I. Hypertension. Spilker B. Quality of Life and Pharmacoeconomics in Clinical Trials. Second edition :1996;893-902 Lippincott-Raven, Philadelphia, PA.
37. Wiklund I., Dimenäs E., Wahl M. Factors of importance when evaluating quality of life in clinical trials. Control. Clin. Trials. 11:1990;169-179.
38. Holst J., Bäckström T., Hammarbäck S., von Schoultz B. Progestogen addition during oestrogen replacement therapy - effects on vasomotor symptoms and mood. Maturitas. 11:1989;13-20.
39. Dennerstein L., Burrows G. Psychological effects of progestogens in the postmeno-pausal years. Maturitas. 8:1986;101-106.
40. Nedstrand E., Wijma K., Lindgren M., Hammar M. The relationship between stress-coping and vasomotor symptoms in postmenopausal women. Maturitas. 31:1998;29-34.
41. Holte A., Mikkelsen A. Psychosocial determinants of climacteric complaints. Maturitas. 13:1991;205-215.
42. Ballinger S.E. Psychosocial stress and symptoms of menopause: a comparative study of menopause clinic patients and non-patients. Maturitas. 7:1985;315-327.
43. Kaufert P.A., Gilbert P., Hassard T. Researching the symptoms of menopause: an exercise in methodology. Maturitas. 10:1988;117-131.
44. Abraham S., Llewellyn-Jones D., Perz J. Changes in Australian women's perception of symptoms in peri-menopausal women. Maturitas. 9:1987;235-251.
45. Avis N.E., McKinlay S.M. A longitudinal analysis of women's attitudes toward the menopause: results from the Massachusetts Women's Health study. Maturitas. 13:1991;65-79.
46. Matthews K.A. Myths and realities of the menopause. Psychosom. Med. 54:1992;1-9.
47. Daly E., Gray A., Barlow D., et al. Measuring the impactof menopausal symptoms on quality of life. Br. Med. J. 307:1993;836-840.
48. Oldenhave A., Jaszmann L.J.B., Haspels A.A., Everaerd W.T.A.M. Impact of climacteric on well-being. Am. J. Obstet. Gynecol. 168:1993;772-780.
49. Ballinger C.B., Browning M.C.K., Smith A.H.W. Hormone profiles and psychological symptoms in peri-menopausal women. Maturitas. 9:1987;235-251.
50. Gerdes L.C., Sonnendecker E.W.W., Polakow E.S. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women. Am. J. Obstet. Gynecol. 142:1982;98-104.